ANRO · Alto Neuroscience, Inc.
$27.23
+0.16 (+0.59%)
At close · Jul 22
Market Cap
$955.61M
Shares
35.09M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-10-27 | New | Pharmaceuticals | $49,999,533 | $49,999,533 | 06b |
| 2023-11-27 | New | Biotechnology | $31,887,138 | $31,887,138 | 06b |
| 2023-11-27 | New | Biotechnology | $45,000,223 | $45,000,223 | 06b |
| 2023-11-27 | New | Biotechnology | $59,261,815 | $59,261,815 | 06b |
| 2023-11-27 | New | Biotechnology | $7,722,217 | $7,722,217 | 06b |
Showing 1–5 of 5 filings